Background and Purpose: Population-wide reductions in cardiovascular disease incidence
and mortality have not been shared equally by African Americans. The burden of …

Objective: To appropriately identify and treat noncommunicable diseases (NCDs) among
persons living with HIV (PLHIV) in low-and-middle-income countries (LMICs), it is imperative …

Summary Background Sub-Saharan Africa is in rapid demographic transition, and non-
communicable diseases are increasingly important causes of morbidity and mortality. We …

Although antiretroviral therapy for HIV infection prevents AIDS-related complications and
prolongs life, it does not fully restore health. Long-term treated patients remain at higher than …

With widespread availability and the use of antiretroviral therapy, patients with human
immunodeficiency virus (HIV) in the United States are living long enough to experience non …

Description: After HIV diagnosis, timely entry into HIV medical care and retention in that care
are essential to the provision of effective antiretroviral therapy (ART). Adherence to ART is …

Background The SMART study was a trial of intermittent use of antiretroviral therapy
(ART)(drug conservation [DC]) versus continuous use of ART (viral suppression [VS]) as a …

Systemic immune activation is increased in HIV-infected individuals, even in the setting of
virus suppression with antiretroviral therapy. Although numerous factors may contribute …

HIV infection can result in stroke via several mechanisms, including opportunistic infection,
vasculopathy, cardioembolism, and coagulopathy. However, the occurrence of stroke and …

Cardiovascular disease, and particularly coronary heart disease, is an emerging area of
concern in the HIV population. Since the advent of efficient antiretroviral therapies and the …